Fospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol (2,6-diisopropylphenol)

Bibliography

• Kay B, Rolly G. I.C.I. 35868–The effect of a change of formulation on the incidence of pain after intravenous injection. Acta Anaesthesiol Belg 1977;28:317
   PubMedGoogle Scholar
• Kay B, Rolly G. I.C.I. 35868, a new intravenous induction agent. Acta Anaesthesiol Belg 1977;28:303
   PubMedGoogle Scholar
• Glen JB. Animal studies of the anaesthetic activity of ICI 35 868. Br J Anaesth 1980;52:731
   PubMed Web of Science ®Google Scholar
• Glen JB, Hunter SC. Pharmacology of an emulsion formulation of ICI 35 868. Br J Anaesth 1984;56:617
   PubMed Web of Science ®Google Scholar
• Bachmann-Mennenga B, Ohlmer A, Heesen M. Incidence of pain after intravenous injection of a medium-/long-chain triglyceride emulsion of propofol. An observational study in 1375 patients. Arzneimittelforschung 2003;53:621
   PubMed Web of Science ®Google Scholar
• Eddleston JM, Shelly MP. The effect on serum lipid concentrations of a prolonged infusion of propofol–hypertriglyceridaemia associated with propofol administration. Intensive Care Med 1991;17:424
   PubMed Web of Science ®Google Scholar
• Fukada T, Ozaki M. Microbial growth in propofol formulations with disodium edetate and the influence of venous access system dead space. Anaesthesia 2007;62:575
   PubMed Web of Science ®Google Scholar
• Seeberger MD, Staender S, Oertli D, et al. Efficacy of specific aseptic precautions for preventing propofol-related infections: analysis by a quality-assurance programme using the explicit outcome method. J Hosp Infect 1998;39:67
   PubMed Web of Science ®Google Scholar
• Egan TD, Kern SE, Johnson KB, Pace NL. The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol) versus propofol in a lipid formulation (Diprivan): an electroencephalographic and hemodynamic study in a porcine model. Anesth Analg 2003;97:72
   PubMed Web of Science ®Google Scholar
• Kim KM, Choi BM, Park SW, et al. Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion. Anesthesiology 2007;106:924
   PubMed Web of Science ®Google Scholar
• Morey TE, Modell JH, Shekhawat D, et al. Preparation and anesthetic properties of propofol microemulsions in rats. Anesthesiology 2006;104:1184
   PubMed Web of Science ®Google Scholar
• Ravenelle F, Vachon P, Rigby-Jones AE, et al. Anaesthetic effects of propofol polymeric micelle: a novel water soluble propofol formulation. Br J Anaesth 2008;101:186
   PubMed Web of Science ®Google Scholar
• Banaszczyk MG, Carlo AT, Millan V, et al. Propofol phosphate, a water-soluble propofol prodrug: in vivo evaluation. Anesth Analg 2002;95:1285
   PubMed Web of Science ®Google Scholar
• Martinasevic MK, Green MD, Baron J, Tephly TR. Folate and 10-formyltetrahydrofolate dehydrogenase in human and rat retina: relation to methanol toxicity. Toxicol Appl Pharmacol 1996;141:373
   PubMed Web of Science ®Google Scholar
• d'Alessandro A, Osterloh JD, Chuwers P, et al. Formate in serum and urine after controlled methanol exposure at the threshold limit value. Environ Health Perspect 1994;102:178
   PubMed Web of Science ®Google Scholar
• Wallage HR, Watterson JH. Formic acid and methanol concentrations in death investigations. J Anal Toxicol 2008;32:241
   PubMed Web of Science ®Google Scholar
• Dhareshwar SS, Stella VJ. Your prodrug releases formaldehyde: should you be concerned? No! J Pharm Sci 2008;97:4184
   PubMed Web of Science ®Google Scholar
• Thompson CA. Fospropofol approved for monitored anesthesia care. Am J Health Syst Pharm 2009;66:206
   PubMedGoogle Scholar
• Fechner J, Ihmsen H, Hatterscheid D, et al. Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion. Anesthesiology 2004;101:626
   PubMed Web of Science ®Google Scholar
• Fechner J, Ihmsen H, Hatterscheid D, et al. Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers. Anesthesiology 2003;99:303
   PubMed Web of Science ®Google Scholar
• Fechner J, Ihmsen H, Schiessl C, et al. Sedation with GPI 15715, a water-soluble prodrug of propofol, using target-controlled infusion in volunteers. Anesth Analg 2005;100:701
   PubMed Web of Science ®Google Scholar
• Gibiansky E, Struys MM, Gibiansky L, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 1): pharmacokinetics. Anesthesiology 2005;103:718
   PubMed Web of Science ®Google Scholar
• Schywalsky M, Ihmsen H, Tzabazis A, et al. Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats. Eur J Anaesthesiol 2003;20:182
   PubMed Web of Science ®Google Scholar
• Struys MM, Vanluchene AL, Gibiansky E, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safety. Anesthesiology 2005;103:730
   PubMed Web of Science ®Google Scholar
• Shah A, Mistry B, Gibiansky E, Gibiansky L. Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation. Anesthesiology 2008;109:937; discussion 937
   PubMed Web of Science ®Google Scholar
• Shah A, Mistry B, Gibiansky E, Gibiansky L. Fospropofol assay: issues and impact on pharmacokinetic and pharmacodynamic evaluation. Eur J Anaesthesiol 2009;26:81; discussion 81
   PubMedGoogle Scholar
• Shah A, Mistry B, Gibiansky E, Gibiansky L. Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation. Anesth Analg 2009;108(1):382
   PubMedGoogle Scholar
• Shah A, Fechner J, Struys M, Mistry B. Differential PK/PD of propfol after intravenous fospropofol and diprivan in healthy subjects. Anesthesiology 2007;107:A46
   Google Scholar
• Cohen LB. Clinical trial: a dose-response study of fospropofol disodium for moderate sedation during colonoscopy. Aliment Pharmacol Ther 2008;27:597
   PubMed Web of Science ®Google Scholar
• Silvestri GA, Vincent BD, Wahidi MM, et al. A phase 3, randomized, double-blind study to assess the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest 2009;135:41
   PubMed Web of Science ®Google Scholar
• Leslie B, Cohen LB, Silvestri G. Clinical safety of fospropofol disodium sedation during diagnostic and therapeutic procedures anesthesiology. ASA abstract 2008;A190
   Google Scholar
• Levitzky BE, Vargo JJ. Fospropofol disodium injection for the sedation of patients undergoing colonoscopy. Ther Clin Risk Manag 2008;4:733
   PubMedGoogle Scholar
• Vargo JJ, Bramley T, Meyer K, Nightengale B. Practice efficiency and economics: the case for rapid recovery sedation agents for colonoscopy in a screening population. J Clin Gastroenterol 2007;41:591
   PubMed Web of Science ®Google Scholar
• Yavas S, Lizdas D, Gravenstein N, Lampotang S. Interactive web simulation for propofol and fospropofol, a new propofol prodrug. Anesth Analg 2008;106:880
   PubMed Web of Science ®Google Scholar
• Kumpulainen H, Jarvinen T, Mannila A, et al. Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol. Eur J Pharm Sci 2008;34:110
   PubMed Web of Science ®Google Scholar